DENTSPLY SIRONA Inc.·4

Mar 6, 5:24 PM ET

Johnson Robert Anthony 4

4 · DENTSPLY SIRONA Inc. · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

DENTSPLY SIRONA (XRAY) SVP Robert Anthony Johnson Receives Equity Award

What Happened

  • Robert Anthony Johnson, SVP & Chief Supply Chain Officer of DENTSPLY SIRONA (XRAY), received equity awards on 2026-03-04 totaling 247,343 units: 44,643 restricted stock units (RSUs) and 202,700 derivative awards (options). Both grants are reported as acquisitions at $0.00 per share (typical for compensation grants).

Key Details

  • Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (appears timely).
  • Grant amounts: 44,643 RSUs and 202,700 derivative awards (total 247,343).
  • Reported price: $0.00 (award/grant at no cash purchase).
  • Vesting: RSUs vest in one-third annual increments over 3 years, ending March 4, 2029 (Footnote F1). Options vest on the same schedule (Footnote F2).
  • Option exercise price: set at 110% of the issuer’s closing common stock price on the grant date (per Footnote F2).
  • Shares owned after the transaction: not stated in the provided filing details.
  • Filing code: A (award/grant). No 10b5-1 or tax-withholding details disclosed in the summary provided.

Context

  • RSUs convert to actual shares only as they vest; the options have value only if the stock price rises above the 110% exercise price. These grants are standard executive compensation, not an open-market purchase or sale, and do not by themselves signal a near-term buy/sell action.

Insider Transaction Report

Form 4
Period: 2026-03-04
Johnson Robert Anthony
SVP, Chief Supply Chain Office
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-04+44,643161,819.146 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-03-04+202,700202,700 total
    Exercise: $14.78From: 2027-03-04Exp: 2036-03-04Common Stock (202,700 underlying)
Footnotes (2)
  • [F1]Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029.
  • [F2]Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.
Signature
/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson|2026-03-06

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT